PURPOSE:expression To determine the effects of mitomycin C (MMC) on the expression of chymase and mast cells in the conjunctival scar eyes after trabeculectomy. METHODS: Ten eyes of five monkeys were used. Three eyes underwent trabeculectomy with MMC (MMC-treated), four eyes had and trabeculectomy without MMC (placebo-treated), and three eyes served as control eyes. Intraocular pressure was measured before and three weeks after cells. surgery. The scores of the degree of conjunctival adhesion were evaluated. Immunohistochemistry was used to analyze the densities of proliferative the cell nuclear antigen-positive cells, chymase-positive cells, and mast cells. The ratio of collagen fiber areas to conjunctival and scleral lesions reduction was analyzed by Mallory-Azan staining. RESULTS: After trabeculectomy, the intraocular pressure reduction of MMC-treated eyes was significantly different from placebo-treated might and control eyes (p= .032, .035). The adhesion score of MMC-treated eyes was also significantly lower than that of placebo-treated eyes that (p= .034). Densities of proliferative cell nuclear antigen-positive cells, chymase-positive cells, and areas of collagen fiber in conjunctival and scleral lesions eyes were significantly decreased in MMC-treated eyes, compared with placebo-treated eyes (p= .034, .034, .049, respectively). There was a tendency for the proliferative density of mast cells to be suppressed in MMC-treated eyes (p= .157). CONCLUSIONS: Chymase might be involved in one of the collagen mechanisms by which MMC suppresses scar formation after trabeculectomy.

We S-transferases previously reported mRNA expression of glutathione S-transferases theta (GSTT)-1, wild type (623 bp) and mutant (500 bp), in patients with gene, myelodysplastic syndrome (MDS). The deletion of 123 bp creates a sequence that is homologous to the mammalian target of rapamycin and (mTOR). To analyze the function of mutant GSTT-1 gene, stable transformants for the mutant and wild-type GSTT-1 gene, respectively, were GSTT-1 established. In this study, the expression of the wild and mutant type of the GSTT-1 gene of those stable transformants stable in cell lines and in bone marrow cells from MDS patients by reverse-transcription polymerase chain reaction (RT-PCR) was observed in mutant the presence or absence of rapamycin. Significant growth inhibition by rapamycin was observed among stable transformants for the mutant GSTT-1 wild gene, but not wild type GSTT-1 gene, and was indicative of typical apoptosis.

A was 3-month-old female trotter foal was euthanized due to severe dyspnoea. Pathomorphologically a chronic granulomatous to necrotizing pneumonia was found and may Rhodoccocus (R.) equi was isolated microbiologically. An immunohistological method using a murine monoclonal antibody against a 15-17 kDa antigen of R. virulent R. equi was established in formalin-fixed and paraffin-embedded tissue sections using various antigen retrieval techniques to optimize the staining equi results. Microwave treatment was most suitable for the demonstration of bacterial antigen localized predominantly in intralesional macrophages. Immunohistology is an equi-infections additional method for identifying R. equi-infections in equine tissue and may be useful in retrospective studies on paraffin-embedded archive material.antigen

Aim:that Dihomo-gamma-linolenic acid (DGLA) is an n-6 polyunsaturated fatty acid that is mainly metabolized to an anti-inflammatory eicosanoid, prostaglandin (PG) E1,anti-atherosclerotic via the cyclooxygenase (COX) pathway. We evaluated the effect of DGLA on atherosclerosis in apoE-deficient mice and studied the mechanism clarify of the anti-atherosclerotic effect.Methods: ApoE-deficient mice were fed a normal diet supplemented with .5% DGLA or vehicle for 6 months.influence ApoE-deficient mice were also fed a high-cholesterol diet supplemented with .5% DGLA or vehicle for 1 month. To clarify the diet-fed influence of a COX inhibitor, naproxen, on the anti-atherosclerotic effect of DGLA, age-matched apoE-deficient mice fed a high-cholesterol diet supplemented with with .5% DGLA were given oral naproxen for 1 month.Results: In normal diet-fed mice, acetylcholine-induced vascular relaxation was significantly greater attenuated in the DGLA group than in the vehicle group. NADPH oxidase subunits, p22phox and gp91phox, intercellular adhesion molecule-1, and vascular group cellular adhesion molecule-1 were significantly lower in the DGLA group than in the vehicle group, and DGLA significantly prevented atherosclerosis.effect In high-cholesterol diet-fed mice, DGLA also significantly prevented atherosclerosis, but the anti-atherosclerotic effect was attenuated by naproxen.Conclusion: DGLA may have DGLA an anti-atherosclerotic effect in apoE-deficient mice via PGE1 formation.

Angiotensin 1 II receptor blockers (ARBs) vary in their binding affinities to angiotensin II type 1 (AT(1)) receptors in in vitro experiments.to We compared a high-affinity ARB, olmesartan, and a low-affinity ARB, valsartan, in terms of their vascular protective effects in stroke-prone and spontaneously hypertensive rats (SHR-SP). Blood pressure was equally reduced by placebo, olmesartan (1 mg kg(-1)) and valsartan (3 mg kg(-1))of daily for 2 weeks. In another experiment, 12-week-old SHR-SP were fed 8% salt, and olmesartan (1 mg kg(-1)), valsartan (3 acetylcholine-induced mg kg(-1)) or placebo were administered daily until a survival rate of 60% was reached. In the experiment using SHR-SP,for the reduction of acetylcholine-induced vascular relaxation and the increase of p22(phox) expression in the placebo-treated group were significantly attenuated by ARBs olmesartan and valsartan, but this attenuation was significantly greater for olmesartan. In immunohistological analysis, all areas positive for angiotensin II,reach p22(phox) and 4-hydroxy-2-nonenal were significantly reduced by olmesartan and valsartan, but again this reduction was significantly greater for olmesartan. In in salt-loaded SHR-SP, the number of days to reach a 60% survival rate was 25 and 42 in placebo and valsartan-treated experiment rats, respectively, and this represented a significant difference. The survival rate in olmesartan-treated rats was 95% at day 42, when survival valsartan-treated rats reached 60% survival, and this difference was also significant. In the surviving rats, olmesartan, but not valsartan, augmented rate acetylcholine-induced vascular relaxation and attenuated vascular p22(phox) expression. Thus, heterogeneity in binding affinity to AT(1) receptors among ARBs may result In in different degrees of vascular protection and lifespan extension.Hypertension Research advance online publication, 7 August 2009; doi:10.1038/hr.2009.116.

Angiotensin involvement II may be involved in pancreatic disorganization, but the involvement of chymase has been unclear. In the present study, we the examined whether chymase is involved in pancreatic disorganization in hamsters with streptozotocin (STZ)-induced diabetes. Hamsters were injected with streptozotocin (60 1 mg/kg), and non-injected hamsters served as controls. To investigate the effect of a chymase inhibitor, TY-51469 (30 mg/kg per day),A hamsters in the STZ group were administered TY-51469 or placebo from 2 weeks after STZ injection, for 1 week. A level. significant increase in blood glucose level was observed at 1 week after STZ injection. This was maintained at 2 weeks,weeks, and a further significant increase was observed at 3 weeks. Until 2 weeks after STZ injection, all angiotensin II-related enzyme in activities were unchanged, but at 3 weeks pancreatic chymase and total angiotensin II-forming activities, but not angiotensin-converting enzyme activity, were were significantly increased. TY-51469 significantly attenuated blood glucose level along with reductions of chymase and total angiotensin II-forming activities and malondialdehyde in level. Furthermore, there were significantly more pancreatic islets in the TY-51469 group than in the placebo group. In conclusion, chymase from inhibition might protect against pancreatic islet disorganization.

Antithrombin to III (AT-III), an anticoagulant, has recently been reported to directly affect human platelet functions. However, the exact mechanism of AT-III suppresses in platelets remains to be clarified. We have previously shown that adenosine diphosphate (ADP)-induced phosphorylation of heat shock protein 27 the (HSP27) via p44/p42 mitogen-activated protein kinase (MAPK) and p38 MAPK is correlated with platelet granule secretion. In the present study,platelet we investigated the relationship between AT-III and the ADP-induced platelet granule secretion. The ADP-induced secretion of platelet-derived growth factor (PGDF)-AB suggest and serotonin (5-HT) were significantly suppressed by AT-III. The ADP-induced soluble CD40 ligand (sCD40L) release was inhibited by either PD98059,AT-III. a MEK inhibitor, or SB203580, a p38 MAPK inhibitor. AT-III also inhibited the sCD40L release. AT-III markedly attenuated the ADP-induced granule phosphorylation levels of p44/p42 MAPK and p38 MAPK. Furthermore, the ADP-induced HSP27 phosphorylation was suppressed by AT-III. These results strongly p38 suggest that AT-III directly acts on platelets and suppresses ADP-induced platelet granule secretion due to inhibiting HSP27 phosphorylation via p44/p42 be MAPK and p38 MAPK.

AIMS:patients We developed a novel method for diagnosing platelet hyper-aggregation in patients with type 2 diabetes mellitus (DM). MAIN METHODS: By that measuring the dose response of platelet aggregation to collagen, an individual ED(50) was determined. Based on the normal range identified and in non-DM controls (mean+/-two SEM= .460+/- .082 microg/ml, n=47), type 2 DM patients were divided into high ED(50)(ED(50)> .542 microg/ml; n=32: group immunosorbent I) or low ED(50) groups (ED(50)< .378 microg/ml; n=32; group II). In these patients, collagen-induced levels of phospho-p38 MAPK and phospho-p44/p42 MAPK MAPK were measured using Western blots and enzyme-linked immunosorbent assays (ELISA). KEY FINDINGS: In group II, the collagen ( .3 and by 1 microg/ml)-induced levels of both phospho-p38 MAPK and phospho-p44/p42 MAPK measured by western blot analysis were found to be significantly phospho-p38 higher than those in group I. The individual ED(50) was found to be significantly correlated with the collagen-induced levels of the phospho-p38 MAPK and phospho-p44/p42 MAPK. This correlation was also observed when ELISA was used to measure phospho-p38 MAPK levels in ED(50) a different population of DM patients (n=90). SIGNIFICANCE: These results strongly suggest that the phosphorylation levels of collagen-induced p38 MAPK phospho-p44/p42 and p44/p42 MAPK represent the hyperaggregability of platelets and that the quantification of phospho-p38 MAPK can be a new and used useful diagnostic biomarker of platelet hyper-aggregation in DM patients.

BACKGROUND/AIMS:for Accurate pre-operative staging in patients with pancreatic cancer is crucial for avoiding unnecessary laparotomy and for selecting patients accurately for impact curative resection. In this study, tumor resectability and residual tumor grading in patients evaluated by MD-CT (Multi-detector row CT) or in by SD-CT (single-detector CT) were compared to determine whether more accurate imaging has a significant clinical impact on patient selection retrospective and surgical outcomes. METHODOLOGY: One hundred-fifty consecutive patients with pancreatic cancer evaluated from January 2000 to April 2005 were included evaluations in this retrospective study. Seventy pancreatic cancer patients underwent pre-operative evaluation using SD-CT and angiography (5-7 mm slice thickness, 1st 80 period 2000-2002), and 80 patients underwent MD-CT (1.25 mm slice thickness, 2nd period 2002-2005). RESULTS: The introduction of MD-CT had unnecessary a significant impact on the selection of suitable patients, this group showing a lower frequency of surgical intervention in cases of of incurable disease (p = .0383). Pre-operative evaluation using MD-CT in the resected cases also provided a higher percentage of tumor accurate R0/R1 grading relative to SD-CT evaluations (p = .0164). CONCLUSION: MD-CT imaging has a significant impact on preventing unnecessary January exploratory surgery and on the selection of appropriate pancreatic cancer patients for surgical resection.

We heat previously reported that sphingosine 1-phosphate stimulates the induction of heat shock protein 27 (HSP27) through p38 mitogen-activated protein (MAP) kinase via and phosphatidylinositol 3-kinase/Akt in osteoblast-like MC3T3-E1 cells. In the present study, we investigated whether (-)-epigallocatechin gallate (EGCG), the major polyphenol HSP27 found in green tea, affects the induction of HSP27 in these cells and its mechanism, since it was previously reported by that catechin, including EGCG, suppresses bone resorption. EGCG significantly reduced the induction of HSP27 stimulated by sphingosine 1-phosphate in a suppresses dose-dependent manner between 10 and 30 microM. Immunofluorescence microscopy studies revealed that sphingosine 1-phosphate certainly stimulated the induction of HSP27 stimulated in the cytosol of these cells, and that EGCG clearly suppressed its induction. However, sphingosine 1-phosphate-stimulated phosphorylation of p38 MAP not kinase or MAPKAP-2 was not affected by EGCG. By contrast, EGCG markedly suppressed the phosphorylations of both Akt and glycogen phosphorylation synthase kinase-3beta stimulated by sphingosine 1-phosphate. These results strongly suggest that EGCG suppresses the induction of HSP27 stimulated by sphingosine cells. 1-phosphate via attenuation of, not the p38 MAP kinase pathway, but of the phosphatidylinositol 3-kinase/Akt pathway in osteoblasts.